Get the latest tech news
Anti-nausea drug lowers risk of death from aggressive breast cancer by 39% | An anti-nausea drug used to combat the side effects of chemo can improve breast cancer outcomes
A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive breast cancers live longer, cutting the risk of death by up to 39% in some cases, according to a new study.
A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive breast cancers live longer, cutting the risk of death by up to 39% in some cases, according to a new study. For the present observational study, the researchers used Norwegian health registry data from 13,811 women diagnosed with invasive early-stage breast cancer between 2008 and 2020, all of whom received chemotherapy and anti-nausea drugs. Nonetheless, if its effects are confirmed in randomized trials, aprepitant could be repurposed as a cancer therapy, not just for nausea prevention but as a co-treatment to improve survival, especially in high-risk subtypes like TNBC.
Or read this on r/tech
